Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal in situ gel: formulation and characterization.

MLA

Patil, Ruturaj, et al. “Intranasal Administration of Innovative Triamcinolone Acetonide Encapsulated Cubosomal in Situ Gel: Formulation and Characterization.” Drug Development and Industrial Pharmacy, vol. 50, no. 1, Jan. 2024, pp. 68–77. EBSCOhost, https://doi.org/10.1080/03639045.2023.2297275.

APA

Patil, R., Patil, A. S., Chougule, K., Gaude, Y., & Masareddy, R. S. (2024). Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal in situ gel: formulation and characterization. Drug Development and Industrial Pharmacy, 50(1), 68–77. https://doi.org/10.1080/03639045.2023.2297275

Chicago

Patil, Ruturaj, Archana S Patil, Krutuja Chougule, Yadishma Gaude, and Rajashree S Masareddy. 2024. “Intranasal Administration of Innovative Triamcinolone Acetonide Encapsulated Cubosomal in Situ Gel: Formulation and Characterization.” Drug Development and Industrial Pharmacy 50 (1): 68–77. doi:10.1080/03639045.2023.2297275.